J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 2885-2890; DOI 10.1099/vir.0.81906-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, A. I.
Right arrow Articles by Rickinson, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, A. I.
Right arrow Articles by Rickinson, A. B.
Agricola
Right arrow Articles by Bell, A. I.
Right arrow Articles by Rickinson, A. B.
© 2006 Society for General Microbiology

Short Communication

Analysis of Epstein–Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays

Andrew I. Bell1, Katherine Groves1, Gemma L. Kelly1, Debbie Croom-Carter1, Edwin Hui2, Anthony T. C. Chan2 and Alan B. Rickinson1

1 Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
2 Department of Clinical Oncology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong

Correspondence
Andrew I. Bell
a.i.bell{at}bham.ac.uk

Studies of Epstein–Barr virus (EBV)-positive cell lines have identified several forms of virus latency, but the patterns of virus gene expression in EBV-positive tumour cells appear more variable. However, it is unclear to what extent these differences merely reflect the increased sensitivities of different detection methods. Here, the design and validation of novel real-time RT-PCR assays to quantify relative levels of EBV transcripts are described. When the new assays were used to screen a collection of endemic Burkitt's lymphoma tumours, abundant Qp-driven EBNA1 expression was found, whereas the other latent transcripts (with the exception of LMP2A) were either absent or detectable only at trace levels. Analysis of 12 nasopharyngeal carcinoma biopsies revealed significant levels of EBNA1 and LMP2A transcripts in almost every case but, in contrast to previous reports, LMP1 expression was undetectable. These new quantitative assays may help to provide a clearer picture of EBV gene expression in tumour material.

Supplementary methods, a sequence alignment of LMP1 exons 2 and 3, figures showing detection of EBV transcripts by real-time RT-PCR and conventional end-point RT-PCR and a table showing TaqMan primer/probe combinations used to detect EBV transcripts are available in JGV Online.




This article has been cited by other articles:


Home page
BloodHome page
S. Chaganti, C. S. Ma, A. I. Bell, D. Croom-Carter, A. D. Hislop, S. G. Tangye, and A. B. Rickinson
Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients
Blood, August 1, 2008; 112(3): 672 - 679.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. J. Anderson and R. Longnecker
EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway
J. Gen. Virol., July 1, 2008; 89(7): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Mancao and W. Hammerschmidt
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Blood, November 15, 2007; 110(10): 3715 - 3721.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. K. F. Lo, K. F. To, K. W. Lo, R. W. M. Lung, J. W. Y. Hui, G. Liao, and S. D. Hayward
Modulation of LMP1 protein expression by EBV-encoded microRNAs
PNAS, October 9, 2007; 104(41): 16164 - 16169.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Tierney, J. Nagra, I. Hutchings, C. Shannon-Lowe, M. Altmann, W. Hammerschmidt, A. Rickinson, and A. Bell
Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program
J. Virol., September 15, 2007; 81(18): 10092 - 10100.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Fukuda and R. Longnecker
Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway
J. Virol., September 1, 2007; 81(17): 9299 - 9306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2006 by the Society for General Microbiology.